Baroda BNP Paribas Dividend Yield Fund
The scheme seeks to provide medium to long term appreciation by predominantly investing in a well-diversified portfolio of equity and equity related instruments of dividend yielding companies. There is no assurance that the investment objective of the Scheme will be achieved.
Growthvine rating: 2/5 — ranked #116 of 179 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹9.86 (as of 2026-08-21) |
|---|
| AUM | ₹603 Cr |
|---|
| Expense ratio | 2.05% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Himanshu Singh |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 1 year |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | -18.73% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 54.6% of NIFTY Alpha 50's upside and 53.5% of its downside.
Market cap allocation
| Large cap | 67.5% |
|---|
| Mid cap | 30.7% |
|---|
| Small cap | 1.8% |
|---|
Concentration
| Top 5 holdings | 26.1% |
|---|
| Top 10 holdings | 41.5% |
|---|
| Total holdings | 41 |
|---|
Top holdings
- Reliance Industries Ltd — 6.6%
- ICICI Bank Ltd. — 5.3%
- HDFC Bank Ltd. — 5.1%
- Torrent Pharmaceuticals Ltd. — 4.7%
- Larsen & Toubro Limited — 4.4%
- GE Vernova T&D India Limited — 3.5%
- Divis Laboratories Ltd. — 3.3%
- Sun Pharmaceutical Industries Ltd. — 3.0%
- Radico Khaitan Ltd. — 2.8%
- Clearing Corporation of India Ltd — 2.8%
Top sectors
- Banking & Financial — 17.8%
- Pharma & Biotech — 13.7%
- Automobile — 10.5%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | -0.1% | Q3 | #125 of 167 |
| 2025 | 5.5% | Q2 | #52 of 132 |